MIT Technology Review September 29, 2023
Cassandra Willyard

Artificial wombs are nearing human trials. But the goal is to save the littlest preemies, not replace the uterus.

On September 19, US Food and Drug Administration advisors met to discuss how to move research on artificial wombs from animals into humans. These medical devices are designed to give extremely premature infants a bit more time to develop in a womblike environment before entering the outside world. They have been tested with hundreds of lambs (and some piglets), but animal models can’t fully predict how the technology will work for humans.

“The most challenging question to answer is how much unknown is...

Today's Sponsors


Today's Sponsor


Topics: FDA, Govt Agencies, Medical Devices, Patient / Consumer, Provider
Medtronic drops $738m takeover of wearable insulin pump firm
MedKitDoc Founder Develops Advanced Telemedicine Platform Integrating Medtech for Effective Remote Healthcare
47 most responsible healthcare companies: Newsweek
FemTech: Mosie Baby Awarded FDA Clearance for At-Home Intravaginal Insemination
Medtronic scores European approval for rechargeable deep-brain stimulation implant

Share This Article